About Intomics
Intomics is a Healthcare company based in Lyngby (Denmark) founded in 2008, and was acquired by ZS in May 2022. Bionformatics data analysis services. Intomics has raised $372.03 thousand across 3 funding rounds from investors including ZS, European Union and SEED Capital. The company has 27 employees. Intomics was last valued at $1.38 million in December 2021. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Informatics. Its legal entity is INTOMICS A / S.
Company details
Intomics was founded in 2008 and is based in Lyngby, Denmark. Operations focus on the bioinformatics sector, where biomedical big data is analyzed and integrated through the InBio Platform, which employs proprietary algorithms for mining heterogeneous data sources. Key services encompass drug target identification, biomarker discovery, translational research support, drug repositioning for new disease applications, and personalized medicine solutions.
- Headquarters Lyngby, Denmark
- Employees 27
- Stage Acquired
- SectorsHealthcare
- Website intomics.com
- Social LinkedIn X
- Acquired by ZS (May 2022)
- Legal Name Intomics A / S
Funding Insights of Intomics
Intomics has successfully raised a total of $372.03K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $40.3 thousand completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $372,031
- Total Rounds 3
- Last Round Seed — $40,298
- First Round $331,733
(Jun 2009)
- Investors Count 2
All 3 funding rounds of Intomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2021 | $40,298 | Seed | $1.38M | – | – |
| Mar 2021 | $358,283 | Grant | – | – | |
| Jun 2009 | $331,733 | Seed | $1.57M | Seed Capital | – |
| Date | Valuation | Stage |
|---|---|---|
| Dec 2021 | $1.38M | •••••••• |
| Jun 2009 | $1.57M | •••••••• |
Last known valuation $1.38M (Dec 2021). 3 investors in total: 3 institutional.
Investors in Intomics
Intomics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include ZS, European Union and SEED Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm backing Nordic tech startups from seed to Series A with investments in Consumer, Deep Tech, and related sectors. | seedcapital.dk | |||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Strategic and management consulting services are provided worldwide. | 1983 | zs.com | Evanston, United States |
Investor details for Intomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Intomics
5 dated milestones of Intomics across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Intomics is founded.
- Funding First funding round of $332K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $40K.
- Exit Acquired by ZS.
Web traffic of Intomics
Websites that share an audience with Intomics (intomics.com).
Websites whose visitors overlap most with Intomics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| sccwrp.org | 100% | 9.4K | #2,401,490 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Intomics
Complete news archive for Intomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Intomics
Intomics was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Intomics is headquartered in Lyngby, Denmark. It is registered at Lyngby, Region Hovedstaden, Denmark.
Intomics is a funded company, having raised a total of $372.03K across 3 funding rounds to date. The company's 1st funding round was a Seed of $331.73K, raised on Jun 2009.
Intomics has 27 employees.
Intomics was founded in 2008 and is based in Lyngby, Denmark. Operations focus on the bioinformatics sector, where biomedical big data is analyzed and integrated through the InBio Platform, which employs proprietary algorithms for mining heterogeneous data sources. Key services encompass drug target identification, biomarker discovery, translational research support, drug repositioning for new disease applications, and personalized medicine solutions.
Intomics has 3 investors. Key investors include ZS, European Union, and SEED Capital.
The valuation of Intomics is $1.38M as of Dec 2021.
Intomics operates through Intomics A / S.
Yes. Intomics was acquired by ZS in May 2022.